Pharmaceutical

Lupin and Zentiva in licence and supply deal for Certolizumab Pegol

Zentiva Group has entered a licence and supply agreement with Lupin for the commercialisation of latter’s biosimilar Certolizumab Pegol.

Jul 11, 2025 - 06:00
Lupin and Zentiva in licence and supply deal for Certolizumab Pegol
Zentiva Group has entered a licence and supply agreement with Lupin for the commercialisation of latter’s biosimilar Certolizumab Pegol.
Read the original article

Tags:

Previous Article

How to remain a top CDMO in ADC-led oncology

Next Article

Merck agrees to acquire Verona Pharma for $10bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

PF-07960613 by Pfizer for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval

PF-07960613 by Pfizer for Respiratory Syncytial Virus (...

Jun 14, 2024

Breaking down House Speaker Mike Johnson’s health care plan

Breaking down House Speaker Mike Johnson’s health care ...

Oct 26, 2023

STAT+: When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’

STAT+: When it comes to policing pharma, the FTC says i...

Jan 24, 2024